Contribute
España
Italia
대한민국
日本
Français
Benzinga
Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
757.750.61%
QQQ
709.380.97%
BTC/USD
77048.901.5748%
DIA
520.140.75%
GLD
398.111.3%
TLT
80.811.13%

Bio-Rad Laboratories Inc (BIO) Stock Price, Quote, News & History

BIONYSE
Trade with Public
Trade with Public
$371.06
-5.91-1.57%
Last update: Sep 10, 2:19 PM
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareOptionsStock Report

Bio-Rad Laboratories (BIO) Stock Price, Quote, News & History | Benzinga

Key Statistics

Open
$379.92
Close
-
Volume / Avg.
94.36K / 291.92K
Day Range
$369.33 - $379.92
52 Wk Range
236.73 - 396.23
Market Cap
$10.02B
P/E Ratio
45.92
Dividend Yield
-
Exchange
NYSE
RSI
53
Short Interest
6.91%
Days to Cover
4.82

Recent Bio-Rad Laboratories, Inc. News

Why Elliott Sees Hidden Billions Inside Bio-Rad Laboratories

Elliott Management builds a stake in Bio-Rad (NYSE: BIO) to push for better performance, but family voting control could pose a hurdle.
Vandana Singh

Nasdaq 100 Drops Over 1%, Oil Tops $106 On Iran Impasse: Stock Market Today

Nasdaq sinks 1.1% as AMAT, MU, ORCL and Vertiv crater on AI capex jitters, while WTI tops $106 and the 10-year yield hovers near 4.6% on stalled US-Iran talks.
Piero Cingari

Toyo Posts Upbeat Q1 Earnings, Joins Brady, Dominion Energy And Other Big Stocks Moving Higher On Monday

TOYO shares rose 13.7% after beating earnings expectations. Other top gainers include JLHL, RAMP, HIVE, TE, AUTL, GENI, BRC, BIO, BL, RBLX, ZETA, and D.
Avi Kapoor

Stock Market Today: Apple Earnings Power S&P 500, Nasdaq To Records; Trump Hits EU

U.S. stocks hit fresh records as Apple's blowout Q2 powered Big Tech, while crude oil sank 3% on Hormuz news and Trump set 25% EU auto tariffs.
Piero Cingari

Pinterest Posts Downbeat Results, Joins DraftKings, Toast, Expedia And Other Big Stocks Moving Lower In Friday's Pre-Market Session

Avi Kapoor
40%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
492.60M
Investing Cash Flow (TTM)
-237.10M
Financing Cash Flow (TTM)
-120.80M
Free Cash Flow (TTM)
353.10M
Capital Expenditure (TTM)
-139.50M
Net Change in Cash (TTM)
134.70M

Analyst Trends and Forecast

1
Apr
1
1
May
2
2
Aug
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
2.8
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$9.77B
PE Ratio (TTM)
45.92
PE Ratio (FWD)
41.15
PEG Ratio (TTM)
-
PS Ratio (TTM)
3.92
PB Ratio (TTM)
1.41
Earnings Yield % (TTM)
2.18%
Earnings Yield % (FWD)
2.43%
EV / EBITDA (TTM)
17.21
Price / EBITDA (TTM)
17.86
Price / Free Cash Flow (TTM)
28.73
Book Value / Share
$268.30

Company Debt

Total Debt
$1.20B
LT Debt
$803.00M
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-$500.00K
Total Cash
$517.00M
Debt to Equity
0.19
Issuance of Debt (TTM)
-$500.00K
Repayment of Debt (TTM)
-$500.00K

Key Statistics

Open
$379.92
Close
-
Volume / Avg.
94.36K / 291.92K
Day Range
$369.33 - $379.92
52 Wk Range
236.73 - 396.23
Market Cap
$10.02B
P/E Ratio
45.92
Dividend Yield
-
Exchange
NYSE
RSI
53
Short Interest
6.91%
Days to Cover
4.82

About

Sector
Health Care
Industry
Life Sciences Tools & Services
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and speci...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Bio-Rad Laboratories (BIO) stock?

A

You can purchase shares of Bio-Rad Laboratories (NYSE:BIO) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Bio-Rad Laboratories (BIO) competitors?

Q

What is the forecast, or price target, for Bio-Rad Laboratories (BIO) stock?

A

Bio-Rad Laboratories has a consensus price target of $334.25.

Q

What is the current price for Bio-Rad Laboratories (BIO)?

A

The stock price for Bio-Rad Laboratories (NYSE: BIO) is $371.06 last updated September 10, 2026 at 2:19 PM EDT.

Q

Does Bio-Rad Laboratories (BIO) pay a dividend?

A

There are no upcoming dividends for Bio-Rad Laboratories.

Q

When is Bio-Rad Laboratories (NYSE:BIO) reporting earnings?

A

Bio-Rad Laboratories does not have any upcoming earnings scheduled.

Q

Is Bio-Rad Laboratories (BIO) going to split?

A

There is no upcoming split for Bio-Rad Laboratories.

Q

What sector and industry does Bio-Rad Laboratories (BIO) operate in?

A

Bio-Rad Laboratories is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NYSE.

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved